EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss
Abstract
Authors
T Yu PS Dulai J Griffith D Sharma EV Loftus